Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Early balding men may have insulin resistance, but lifestyle changes can help.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Finasteride safely reduces excessive hair growth in women.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.